The role of discoidin domain receptor 2 in the renal dysfunction of alport syndrome mouse model-Reference-Cited by-同舟云学术

The role of discoidin domain receptor 2 in the renal dysfunction of alport syndrome mouse model

Published:2021-01-01 Issue:1 Volume:43 Page:510-519
ISSN:0886-022X
Container-title:Renal Failure
language:en
Short-container-title:Renal Failure

Author:

Sannomiya Yuya¹,Kaseda Shota¹²,Kamura Misato¹²,Yamamoto Hiroshi³,Yamada Hiroyuki³,Inamoto Masataka³,Kuwazuru Jun¹,Niino Saki¹,Shuto Tsuyoshi¹⁴,Suico Mary Ann¹⁴,Kai Hirofumi¹²⁴

Affiliation:

1. Department of Molecular Medicine Graduate School of Pharmaceutical Sciences, Kumamoto, Japan

2. Program for Leading Graduate Schools “HIGO (Health life science: Interdisciplinary and Glocal Oriented) Program”, Kumamoto University, Kumamoto, Japan

3. Ono Pharmaceutical Co. Ltd, Osaka, Japan

4. Global Center for Natural Resources Sciences, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan

Publisher

Informa UK Limited

Subject

Nephrology,Critical Care and Intensive Care Medicine,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/0886022X.2021.1896548

Reference35 articles.

1. Alport's Syndrome, Goodpasture's Syndrome, and Type IV Collagen

2. Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy

3. A review of clinical characteristics and genetic backgrounds in Alport syndrome

4. Long-term treatment with EGFR inhibitor erlotinib attenuates renal inflammatory cytokines but not nephropathy in Alport syndrome mouse model

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. From pixels to druggable leads: A CADD strategy for the design and synthesis of potent DDR1 inhibitors;Computer Methods and Programs in Biomedicine;2024-09

2. Genetic Modifiers of Mendelian Monogenic Collagen IV Nephropathies in Humans and Mice;Genes;2023-08-25

3. Genetic and pharmacological tools to study the role of discoidin domain receptors in kidney disease;Frontiers in Pharmacology;2022-09-28

4. Discoidin domain receptor 1 may be involved in biological barrier homeostasis;Journal of Clinical Pharmacy and Therapeutics;2022-06-04

5. Identification of novel discoidin domain receptor 1 (DDR1) inhibitors using E-pharmacophore modeling, structure-based virtual screening, molecular dynamics simulation and MM-GBSA approaches;Computers in Biology and Medicine;2022-03